Evidence map›Paper›PMID 25775602›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Universal pathway for posttransfer editing reactions: insights from the crystal structure of TtPheRS with puromycin.

Dmitry Tworowski, Liron Klipcan, Moshe Peretz, Nina Moor, Mark G Safro

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Loss of protein synthesis quality control in host-restricted organisms.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Dmitry TworowskiDepartment of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel;
Liron KlipcanMedical Research Council, Mitochondrial Biology Unit, Cambridge CB2 0XY, United Kingdom; and.
Moshe PeretzDepartment of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel;
Nina MoorInstitute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.
Mark G SafroDepartment of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel; mark.safro@weizmann.ac.il.
Weizmann Institute of Science · ILInstitute of Chemical Biology and Fundamental Medicine · RUMedical Research Council · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the amino acid binding and recognition step, phenylalanyl-tRNA synthetase (PheRS) faces the challenge of discrimination between cognate phenylalanine and closely similar noncognate tyrosine. Resampling of Tyr-tRNA(Phe) to PheRS increasing the number of correctly charged tRNA molecules has recently been revealed. Thus, the very same editing site of PheRS promotes hydrolysis of misacylated tRNA species, associated both with cis- and trans-editing pathways. Here we report the crystal structure of Thermus thermophilus PheRS (TtPheRS) at 2.6 Å resolution, in complex with phenylalanine and antibiotic puromycin mimicking the A76 of tRNA acylated with tyrosine. Starting from the complex structure and using a hybrid quantum mechanics/molecular mechanics approach, we investigate the pathways of editing reaction catalyzed by TtPheRS. We show that both 2' and 3' isomeric esters undergo mutual transformation via the cyclic intermediate orthoester, and the editing site can readily accommodate a model of Tyr-tRNA(Phe) where deacylation occurs from either the 2'- or 3'-OH. The suggested pathway of the hydrolytic reaction at the editing site of PheRS is of sufficient generality to warrant comparison with other class I and class II aminoacyl-tRNA synthetases.

Indexed as

Amino AcidsAnti-Bacterial AgentsBinding SitesCrystallizationCrystallography, X-RayEscherichia coliHydrogen BondingHydrolysisLigandsModels, MolecularMolecular ConformationPhenylalaninePhenylalanine-tRNA LigaseProtein MultimerizationProtein Synthesis InhibitorsPuromycinAmino AcidsAnti-Bacterial AgentsLigandsPhenylalaninePhenylalanine-tRNA LigaseProtein Synthesis InhibitorsPuromycinTyrosineaminoacyl-tRNA synthetasesbiosynthesiseditingpuromycintRNA

Identifiers

PMID25775602
PMCPMC4386372
OpenAlexW2047704870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.